跳至主要内容
临床试验/NCT00462566
NCT00462566已完成不适用

The Efficacy of Motor Cortex Stimulation for Pain Control

Nova Scotia Health Authority2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2005年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Visual Analog scale

研究概览

简要总结

The objective is to determine if motor cortex stimulation works for the following conditions:

  1. Deafferentation facial pain,
  2. Upper extremity complex regional pain syndrome (CRPS) and
  3. Brachial plexus avulsion or phantom limb pain.

Each of these groups of 6 patients (total of 18) will be studied independently and all patients will be implanted with a motor cortex stimulation system. They will be randomised to either a regular or low stimulation setting in the two arms of the study. Each arm will last 3 months.

详细描述

This is a prospective, blinded randomized crossover study comparing two stimulation paradigms in three different groups of patients receiving motor cortex stimulation. The aim of this study is to examine the effectiveness of this modality in a controlled blinded manner, which has not been done in previous studies. There are two primary purposes of this study. The first is to compare two different stimulation paradigms: "high" level stimulation (i.e. stimulator activated 'on' for 10 minutes, 'off' for 2 hours; presumed therapeutic dose); versus "low" stimulation ('on' for 1 minute, 'off' for 6 hours; presumed subtherapeutic dose), in a prospective blinded crossover study design.

The second purpose of this study, is to examine the outcome of MCS in three different pain groups. These are:

  1. Unilateral upper extremity neuropathic pain such as brachial plexus avulsion, stump pain or phantom limb pain
  2. Neuropathic deafferentation facial pain
  3. Upper extremity complex regional pain syndrome (CRPS)

Measurements of the effects of motor cortex stimulation will include a visual analogue scale (VAS) of perceived pain, the McGill Pain Questionnaire, SF-36 quality of life questionnaire, Beck Depression Inventory-II, the standard 7-point patient global impression of change (PGIC), medications log (verified by pharmacy records) and an employment status questionnaire. Adverse events will be recorded at each visit.

Table 1:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis in one of the following three categories:
  • Unilateral upper extremity neuropathic pain such as phantom limb pain, stump pain or brachial plexus avulsion
  • Neuropathic deafferentation facial pain
  • Upper extremity complex regional pain syndrome (CRPS)
  • Pain is refractory to conservative methods (e.g. medications, regional blocks) as reviewed by a chronic pain clinical physician
  • Patient is considered a good candidate for neurosurgery, i.e. no other medical problems that would preclude surgery
  • Patients who are willing to provide informed consent.

排除标准

  • Patients who are not considered medically fit for neurosurgery.
  • Patients who have not exhausted conservative methods of pain control, prior to considering motor cortex stimulation.
  • Patients who are not able to provide informed consent.
  • Patients unable to have magnetic resonance imaging (MRI).

结局指标

主要结局

Visual Analog scale

时间窗: 1 month preop, at 12 and 24 weeks postop

Beck II depression

时间窗: 1 month preop, at 12 and 24 weeks postop

McGill Pain questionnaire

时间窗: 1 month preop, at 12 and 24 weeks postop

Employment status

时间窗: 1 month preop, at 12 and 24 weeks postop

SF-36

时间窗: 1 month preop, at 12 and 24 weeks postop

Medications log

时间窗: 1 month preop, at 12 and 24 weeks postop

Global impression of change

时间窗: at 12 and 24 weeks postop

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验